Results 101 to 110 of about 5,298,587 (157)

The role of FAPI PET/CT in patients with lymphoma: a systematic review

Frontiers in Nuclear Medicine
IntroductionFluorodeoxyglucose (FDG) PET/CT is typically the reference imaging method for assessing and tracking lymphomas. However, fibroblast activation protein inhibitor (FAPI) PET is being explored as a potentially useful option, especially when ...
Natale Quartuccio, Stefania Nicolosi, Sabina Pulizzi, Dante D’Oppido, Salvatore Ialuna   +4 more
doaj   +1 more source

Feasibility of 68Ga-FAPI-46 PET for evaluating active fibrosis in aortic aneurysm

Scientific Reports
Aortic aneurysm (AA) is a disease where aortic wall loses its elasticity, showing fibrosis. Fibroblast activation protein (FAP) expression can be evaluated using radiolabeled FAP-inhibitor (FAPI) PET in fibrosis.
Hoon Young Suh, Jung Woo Byun, Seung-Pyo Lee, Jae Woong Choi, Jin Chul Paeng   +4 more
doaj   +1 more source

Glycyrrhizinate Monoammonium Cysteine-Loaded Lipid Nanoparticles Allow for Improved Acute Liver Injury Therapy

Pharmaceutics
Background: Acute liver injury (ALI) is a prevalent and potentially lethal condition globally, where pharmacotherapy plays a vital role. However, challenges such as rapid drug excretion and insufficient concentration at hepatic lesions often impede the ...
Yunjie Xu, Pinghui Li, Shiran Sun, Yulin Chen, Lixia Feng, Dawei Jiang, Chidan Wan, Jianbo Li, Xiong Cai   +8 more
doaj   +1 more source

Fibroblast Activation Protein Inhibitor PET/CT in Gastric Cancer

Watabe T., Giesel F.L.. Fibroblast Activation Protein Inhibitor PET/CT in Gastric Cancer.
Watabe, Tadashi, Giesel, Frederik L.
core   +1 more source

[⁶⁸Ga]Ga-DOTAGA-Glu(FAPi)₂ Shows Enhanced Tumor Uptake and Theranostic Potential in Preclinical PET Imaging

Diagnostics
The use of fibroblast activation protein inhibitors (FAPis) for positron emission tomography (PET) imaging in cancer has garnered significant interest in recent years, yielding promising results in preclinical and clinical settings.
Julie van Krimpen Mortensen, Simona Mattiussi, Lars Hvass, Emilie Graae Lund, Vladimir Shalgunov, Frank Roesch, Umberto Maria Battisti, Matthias Manfred Herth, Andreas Kjaer   +8 more
doaj   +1 more source

FAPI PET in inflammatory bowel disease: a novel window on fibroblast activity, with unanswered clinical questions

Accurate assessment of inflammatory activity in inflammatory bowel diseases (IBD) such as Crohn’s disease (CD) and ulcerative colitis (UC) remains a major clinical challenge.
Filippi, L, Evangelista, L, Komek, H, Arslan, E   +3 more
core   +1 more source

Preclinical Evaluation and a Pilot Clinical Positron Emission Tomography Imaging Study of [⁶⁸Ga]Ga-FAPI-FUSCC-II

Fibroblast activation protein (FAP), a type II integral membrane serine protease, is a promising target for tumor diagnosis and therapy. OncoFAP has been recently discovered for PET imaging procedures for various solid malignancies.
Bingxin Gu (6715919), Xiao Wang (19312), Zhongyi Yang (206009), Shaoli Song (412493), Xiangwei Wang (145471), Xinyue Du (5958476), Mengjing Ji (17741338), Jianping Zhang (161794), Simin He (3844873), Xiaoping Xu (325842)   +9 more
core   +1 more source

A Fibroblast Activation Protein Inhibitor (FAPI)-Avid Gastric Antral Mass Mimicking Advanced Gastric Cancer: A Case of Presumed Inflamed Gastric Ectopic Pancreas. [PDF]

Cureus
Enaya MA, Albo Ahmed M.
europepmc   +1 more source

Is There an Added Value of Dual-Time-Point [⁶⁸Ga]Ga-Fibroblast Activation Protein Inhibitor (FAPI) PET/CT in Differentiating Malignant and Benign Uptake Findings? [PDF]

Cancers (Basel)
Al-Ibraheem A, Moghrabi S, Alsyouf B, Abdulrahman M, Al-Foqaha M, Al-Tameemi F, Bashabsheh B, Ruzzeh S, Jiad DK, Al-Hammouri AF, Shi H, Abdlkadir AS, Mansour A.   +12 more
europepmc   +1 more source

An Atlas of Gallium-68-fibroblast Activation Protein Inhibitor (FAPI) in Oncology and Nononcology Imaging. [PDF]

Indian J Nucl Med
Solav SV, Jagtap RR, Savale SV.
europepmc   +1 more source